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Summary
Relaxases are proteins responsible for the transfer of
plasmid and chromosomal DNA from one bacterium to
another during conjugation. They covalently react with
a specific phosphodiester bond within DNA origin of
transfer sequences, forming a nucleo-protein complex
which is subsequently recruited for transport by a
plasmid-encoded type IV secretion system. In previ-
ous work we identified the targeting translocation
signals presented by the conjugative relaxase TraI of
plasmid R1. Here we report the structure of TraI trans-
location signal TSA. In contrast to known transloca-
tion signals we show that TSA is an independent
folding unit and thus forms a bona fide structural
domain. This domain can be further divided into three
subdomains with striking structural homology with
helicase subdomains of the SF1B family. We also show
that TSA is part of a larger vestigial helicase domain
which has lost its helicase activity but not its single-
stranded DNA binding capability. Finally, we further
delineate the binding site responsible for transloca-
tion activity of TSA by targeting single residues for
mutations. Overall, this study provides the first evi-
dence that translocation signals can be part of larger
structural scaffolds, overlapping with translocation-
independent activities.
Introduction
Type IV secretion systems (T4SS) are protein complexes
spanning bacterial cell membranes (Alvarez-Martinez
and Christie, 2009; Wallden et al., 2010; Zechner et al.,
2012). They are used to transport biomolecules such as
proteins, nucleic acids and nucleoprotein complexes
across the cell envelope. They can be divided into three
subclasses: (i) the effector protein translocation T4SS
which are responsible for the delivery of effector proteins
into the cytoplasm of eukaryotic cells (Terradot and
Waksman, 2011), (ii) the conjugative systems which
transfer DNA or nucleoprotein complexes from a donor to
a recipient strain in a cell contact-dependent manner
(Fronzes et al., 2009), and finally (iii) T4SS which release
DNA into or mediate uptake from the extracellular milieu
(Hamilton et al., 2005). T4SS have broad clinical signifi-
cance not only as virulence factors but also as a major
vehicle for the dissemination of antibiotic resistance
genes in clinical and natural environments.
T4SS in Gram-negative bacteria are typically composed
of 12 proteins termed VirB1-11 and VirD4 based on the
prototypical Agrobacterium tumefaciens T-DNA delivery
system. The VirB proteins form a large macromolecular
translocation channel embedded in both the inner and
outer membranes (Wallden et al., 2010). T4SS substrates
are thought to be recruited to the VirB machinery by the
VirD4 ATPase, a protein which couples substrate recruit-
ment to secretion and therefore commonly referred to as
the type IV coupling protein (T4CP) (Cabezón et al., 1997;
Schröder and Lanka, 2003; Alvarez-Martinez and Christie,
2009). T4CPs mediate multiple protein–protein interac-
tions with cytoplasmic and inner membrane components of
the secretion system. ATPase activity is associated with
the release and unfolding of complexes between sub-
strates and specific chaperones and is required to energize
the secretion process.
Conjugation systems are the largest and most widely
distributed of the T4SS subtypes. The general mechanism
of nucleoprotein transfer by these systems is well charac-
terized (de la Cruz et al., 2010). Multiple proteins assemble
on the plasmid origin of transfer (oriT) to form the relaxo-
some. This complex prepares the single strand of plasmid
DNA destined for transfer (T-strand) via the nicking–
closing activity of the relaxase enzyme. Initiation of transfer
requires cleavage at a specific position nic, within oriT. The
reaction is mediated by a tyrosine residue of the enzyme so
that a covalent protein–DNAadduct is formed. This nucleo-
protein complex is specifically recognized as a substrate
by the T4CP and actively pumped through the transport
apparatus. Once in the recipient the relaxase-T strand
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intermediate restores the original circular plasmid mol-
ecule by reversion of the strand transfer reaction.
In the paradigm F and related R1 plasmid systems the
192 kDA protein TraI is the substrate of the T4SS encoded
by the tra genes (Everett and Willetts, 1980; Reygers et al.,
1991; Lang et al., 2010; Dostal et al., 2011). This bifunc-
tional protein includes both the relaxase activity and a
helicase that assists unwinding of the T-strand. The relaxo-
some contains the plasmid encoded proteins TraM and
TraY, and the host genome-encoded protein IHF. All of
these factors assist relaxase in nic-cleavage and TraM and
IHF additionally stimulate the helicase (Nelson et al., 1995;
Kupelwieser et al., 1998; Csitkovits and Zechner, 2003;
Sut et al., 2009). Although an additional role for these
accessory proteins is not entirely clear, TraM is thought to
recruit the relaxosome to the T4SS via interaction with the
T4CP TraD (Lu et al., 2008; Wong et al., 2011; 2012). TraI
contains four domains (Fig. 1A): a c. 300 residue relaxase
domain, followed by a single-stranded DNA-binding
domain (extending to residue 822) and a helicase domain
Fig. 1. Crystal structure of TSA.
A. Schematic diagram of the domain structure of TraI. The N-terminal relaxase (light blue), the two translocation signal domains (TSA and
TSB), and the C-terminal domain (dark blue) are indicated, as well as the ssDNA and helicase domains (orange). The domain involved in
T4SS channel activation via TraD-relaxosome interaction in shown in dark green. Boundary residues for each domain except the RecD
domains (the boundaries of which are still unclear) are reported above the diagram.
B. Purification of TSA. Two bands were observed (left panel), one full-length (TSA) and the other resulting from C-terminal degradation
(TSAΔC). Only TSAΔC crystallized. During crystallization, TSAΔC underwent further proteolytic degradation at the N-terminus, resulting in a
band shown at right (TSAcryst).
C. Topology diagram of TSA. TSA contains three domains (here represented in green, orange and blue) which, due to their structural similarity
with domains 2A and 2B of SF1 helicases, are termed ‘2A’, ‘2B’ and ‘2B-like’ (see Fig. 2). This diagram illustrates the overall organization of
the sequence and domain structure as well as secondary structure composition.
D. Crystal structure of TSA. The three structural domains are in ribbon representation and are colour-coded as in (C).
E. Structural homology between the 2B and 2B-like domain. The middle and C-terminal domains of TSA were superimposed. The two
domains are in ribbon representation in the same orientation as domain 2B in (D).
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(the boundaries of this domain are still undefined but the
domain spans approximately a region encompassing resi-
dues 980–1500), and a c. 200 residues domain at the
C-terminus (Dostal and Schildbach, 2010; Lang et al.,
2011). Co-ordinated regulation of ssDNA binding between
the relaxase domain, the ssDNA-binding domain, and the
helicase domain is thought to provide a major control point
for transfer initiation; once cleaved and covalently attached
to the relaxase domain, the plasmid DNA is transferred to
the helicase-associated site to activate ATP-dependent
unwinding. Interaction between TraI and the T4CP TraD is
also key to controlling initiation: TraD indeed stimulates the
relaxase and helicase activities (Mihajlovic et al., 2009; Sut
et al., 2009). Moreover evidence is emerging that a
complex of TraI bound simultaneously to nic and to the
T4CP has a key function in activating the opening of the
T4SS channel (Lang et al., 2011). To study this mecha-
nism, Lang et al. used group 1 RNA phage which utilize
conjugative pili as receptors. The phage genome of ssRNA
with a protein attached to the 3′ end gain access to the cell
interior by a process not yet defined but requiring the
channel subunits and the T4CP. Docking of a relaxosome
substrate to the transport apparatus is necessary for phage
nucleoprotein penetration of the host cell. A minimal func-
tional domain termed ‘the activation domain’ of TraI com-
prising the N-terminal 992 residues including a catalytically
active relaxase is sufficient to enable nucleoprotein uptake
(Fig. 1A; Lang et al., 2011).
Two different mechanisms for the recruitment of
plasmid-loaded relaxosomes to T4CPs have been pro-
posed. In F-like systems TraM binds to oriT and has been
described to bind to the C-terminal domain of TraI
(Ragonese et al., 2007); thus, by mediating binding to
TraD, TraI and the DNA, TraM might mediate recruitment
of the relaxosome to the coupling protein. As an alterna-
tive mechanism, direct binding of relaxases to T4CPs has
been reported in some systems (Szpirer et al., 2000;
Schröder et al., 2002; Cascales and Christie, 2004), but
this has not been observed with R1 proteins (A. Redzej,
unpublished).
The features of a substrate protein that specify it for
secretion have been analysed in a few systems. In some
cases short, C-terminal, signal sequences of positively
charged or hydrophobic residues serve as export signals
for the proteins that contain them (Nagai et al., 2005;
Vergunst et al., 2005). A second group, which includes
TraI, have larger, internally positioned signals. These
regions of TraI, called translocation signals (TS) A (530–
816) and B (1255–1564), target the relaxosome to the
secretion machinery (Lang et al., 2010). Although each TS
alone can confer substrate transport specificity these
regions share nearly no primary sequence similarity except
for a small consensus motif similarly present in the TS of
the R1162 relaxase MobA (Parker and Meyer, 2007). TraI
TSs are widely conserved within the MOBF and MOBQ
families of relaxases (Lang et al., 2010).
In this study we report the crystal structure of the TSA
domain of the TraI protein from the R1 plasmid. We show
that TSA is composed of three domains, each displaying
structural homologies with SF1B helicase family domains.
Based on the TSA structure, site-directed mutagenesis
was performed and the influence of the mutations on
relaxase translocation by the T4S system was evaluated,
thereby identifying the putative recognition interface
within TSA that is involved in specific substrate recogni-
tion and recruitment to the T4S machinery.
Results
The DNA encoding the TSA (530–816) region of TraI of the
R1 plasmid system (Fig. 1A) was cloned in an expression
vector downstream of a sequence encoding a His6-tag and
an Enterokinase cleavage site. The resulting N-terminally
tagged protein was expressed in Escherichia coli. After
Ni-affinity chromatography, two fragments were observed
on SDS-PAGE, one corresponding to TSA’s expected size
(33.7 kDa) and the other shorter at the C-terminus by c.
2–3 kDa, TSAΔC [this shorter fragment still contained its
N-terminal His6-tag as demonstrated using Western blot
analysis and anti-His antibodies (results not shown)].
These fragments could be separated by hydrophobic inter-
action chromatography (Fig. 1B). Both fragments were
subjected to crystallization trials; however, only the smaller
fragment crystallized. Analysis of the protein crystals on an
SDS-PAGE indicated that, in fact, an even smaller frag-
ment had crystallized, TSAcryst: N-terminal sequencing of
the crystallized fragment showed the fragment to start at
residue 570 (Fig. 1B). We have shown that removal of
residues 530–568 lowers only moderately the relative effi-
ciency of translocation, indicating that the crystallized frag-
ment maintains functional integrity (Lang et al., 2010).
No attempt was made to characterize the C-terminal
sequence of the crystallized fragment. This fragment of
TSA crystallized in the space group P41212 with one
molecule in the asymmetric unit. The structure was solved
using the single wavelength anomalous dispersion
phasing method (Rice et al., 2000) from a SelenoMethio-
nine (SeMet)-substituted variant of TSA (TSA contains six
methionines), and refined to a final resolution of 1.85 Å
(Table S1).
A model was built between residues 575 and 786. No
electron density was observed for sequences on either
side of these boundaries, indicating structural disorder
beyond these sequences. The crystal structure of the TSA
domain of the R1 plasmid is composed of three structural
domains named ‘2A, 2B and 2B-like’ for reasons that
are explained below. The 2A domain contains both the
N-terminal and C-terminal ends of the TSAcryst and is
Structure of the TraI translocation signal domain 3
© 2013 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd., Molecular Microbiology
formed by two α-helices and two β strands (Fig. 1C and D,
green). A second and third domains, 2B and 2B-like, are
structurally similar (Fig. 1E) and their fold belongs to the
SH3-like fold family (orange and blue in Fig. 1C and D
respectively). The 2B domain is composed of six β strands
(β2, β8, β9, β10, β11, β12) in an anti-parallel arrangement
forming a central hydrophobic core. The 2B-like domain is
composed of four β strands (β3, β4, β5, β6), two short
helices (C and D) and shares a strand (β7) with the 2B
domain (Fig. 1C). Domain 2B is made of sequences
inserted within domain 2A, while domain 2B-like is made of
sequences inserted within domain 2B (Fig. 1C).
A structural homology search using the DALI server
(Holm and Rosenstrom, 2010) was performed which
resulted in the identification of domain 2 of SF1B helicases
as TSA’s closest structural homologue: the RecD subunit
of the RecBCD helicase ranked first with a Z-score of 8.9 (a
highly significant score), followed by other SF1B helicase
structures. SF1B helicase structures are typically com-
posed of two domains, 1 and 2 (Subramanya et al., 1996;
Korolev et al., 1997), each often split into two, subdomains
A and B, with subdomain B composed of a sequence
inserted in the middle of the sequence of subdomain A.
This domain structure is illustrated in Fig. 2A using the
structure of RecD2 from Deinococcus radiodurans as a
typical example of a helicase structure. In this figure, three
of the four subdomains, 1A, 2Aand 2B, are colour-coded in
yellow, green and orange respectively; domain 1B is not
coloured as it is very small in RecD2. The structural super-
position of TSA and RecD2 resulting from the DALI search
is shown in Fig. 2B. As can be seen, two domains of TSA
superimpose well with parts of subdomains 2A and 2B of
RecD2 and, accordingly, are named TSA 2A and 2B
domains (in green and orange in Figs 1D and 2B; details in
Fig. 2C). The root-means-square deviation (rmsd) in Cα
atoms between TSA and RecD2 equivalent domains 2A
and 2B is 2.7 Å. The third TSA domain (in blue in Fig. 1D)
superimposes well with the 2B domain of TSA (rmsd of
2.4 Å) and thus is named ‘2B-like’ (Fig. 1E). Thus, due to
the high structural homology between TSA and SF1B
helicase subdomains, we can conclude that TSA is part of
a helicase structure, its two first domains, 2A and 2B
Fig. 2. Structural homology between TSA and RecD helicase.
A. Domain structure of RecD. The structure of a RecD homologue (RecD2 from Deinococcus radiodurans; PDB ID PD 1274) is shown in
ribbon representation and in two orientations, 120° apart along the vertical axis. Domains 1A, 2A and 2B of RecD2 are colour-coded yellow,
green and orange respectively.
B. Superposition of the structure of TSA onto the structure of RecD2. RecD2 is in the same orientation as in (A) but is colour-coded in grey.
TSA is in the same orientation and same colour-coding as in Fig. 1D. Orange and green rectangles indicate the regions, the details of which
are shown in (C).
C. Zoom-in on the superimposed parts. The regions within the orange and green rectangles in (B) are zoomed in to provide a visual
illustration of the structural superposition between equivalent domains in TSA and RecD2. As can be seen, the 2A and 2B domains of TSA
superimpose well onto parts of the 2A and 2B domains of RecD2. However, the 2B-like domain is shown not to be a part of the helicase
domain.
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matching parts of the structure of the 2Aand 2B domains of
SF1B helicases. Its third domain, 2B-like, is not part of the
helicase fold but instead protrudes out as a separate
domain which, in the TSA-RecD2 superposition presented
in Fig. 2B, does not clash with any of the other domains of
RecD2. Thus the 2B-like domain of TraI constitutes a
previously uncharacterized addition to the helicase fold,
which here serves as a signal recognition surface linked to
substrate transport.
We next attempted to identify which surfaces in TSA
likely mediate substrate translocation.
The TSA region of TraI from R1 plasmid differs from that
of the F plasmid by only two residues, S757 and H626 in
R1, substituted for T757 and L626 in F. Despite this minor
variation, the T4SS expressed by these two closely related
plasmids can discriminate between the two TraI TSA
sequences and selectively translocate only the cognate
fragment. Exchanging residue 626 of R1 TraI for its coun-
terpart in F was shown to change the substrate selection
fidelity from R1 to F for TSA translocation (Lang et al.,
2010). The crystal structure shows that these residues are
located within the 2B domain and on the concave side of
the arch-like TSA structure (Fig. 3A). No plasmid-specific
discrimination was observed for TSA translocation due to
residue 757 (Lang et al., 2010), so this position may lay
outside the crucial recognition region. To define this region
in more detail we carried outAla andAsn scans on residues
T746, Q736, S739 and D714 (see location of these resi-
dues in Fig. 3A). We also targeted residue 717 and 593,
with the following rationale in mind: R717 is conserved in
Fig. 3. Mapping of investigated surface residues onto the structure of TSA.
A. Mapping of the surface residues mutated in this study. Residues are shown in stick representation. Colour-coding of residues is as follows:
red, pink, yellow and blue depending on whether mutations at these locations impairs TSA translocation function significantly (red), mildly
(pink), not at all (yellow) or stimulate TSA translocation function (blue).
B. Structural alignment of TSA and RecD2 showing the location of the surface residues in the context of the full-length helicase domain.
C. Superposition of the structures of TSA (colour-coded as in the other panels) and of the 381–569 structure (Wright et al., 2012; in yellow)
onto the RecD2 structure (in grey). Three domains of TraI ssDNA-binding domain have homologies with three domains of the helicase fold
(1A, 2A and 2B), suggesting that the ssDNA-binding domain of TraI is a vestigial helicase that has retained ssDNA-binding activity and has
also evolved to function as a TS.
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TSA, TSB, and also MobA of plasmid R1162 and is part of
a small consensus motif; substitution of R717 by Gln in
TSB was shown to affect substrate translocation (Lang
et al., 2010); a nearby insertion (LDR) in MobA also
blocked translocation (Parker and Meyer, 2007), thus, we
mutated R717 to Gln in TSA. Concerning residue 593 (an
Ala in R1 and F TraI proteins), insertion of a 31 residues
sequence after this residue in the TraI relaxase encoded by
the F plasmid eliminated detectable translocation of TSA
(Haft et al., 2006; Lang et al., 2010); so we also sought to
evaluate the effect of mutating this residue to a more bulky
Val side-chain. Note that both R717 and A593 are also in
the 626/757 region (see oval in Fig. 3B).
The different site-specific mutants were generated and
tested in the CRAFT assay, which is based on the fusion of
a Cre reporter enzyme to the protein of interest. Secretion
of the fusion protein is monitored via Cre-mediated recom-
bination of a reporter cassette in recipient cells. Even
though the TSAregion is the minimal fragment sufficient for
protein translocation to the recipient strain during conjuga-
tion (Lang et al., 2010; translocation frequency ∼ 2 × 10−5),
site-specific mutations were introduced into the TraI1–992
construct (translocation frequency ∼ 1 × 10−4) to improve
the readout of the assay and to enable comparisons with
another functional test requiring productive TraI binding
interactions as described below. The expression and
stability of all the mutant variants fused to Cre were evalu-
ated by Western blot analysis (Fig. S1) as well as by
measuring the recombination efficiency upon transforma-
tion (Fig. S2). Recombination efficiency was determined
by introducing the same amount of DNA from each genetic
construct investigated into the reporter strain, and calcu-
lating the number of chloramphenicol-resistant colonies
(recombinants) divided by the number of ampicillin-
resistant colonies (transformants). The results indicated
that Cre-TraI1–992 could catalyse recombination with ∼ 80%
the efficiency of Cre alone, and the rest of the fusion
proteins showed recombination rates between ∼ 80% and
∼ 120% of wild type (Fig. S2). The CRAfT assay results are
presented in Fig. 4 and mapped onto the structure of TSA
in Fig. 3.
Five mutations resulted in significant loss of transloca-
tion activity: A593V, D714N, Q736N, S739A and S739N,
indicating that four residues, 593, 714, 736 and 739 play
an important role as recognition surfaces for substrate
export. In addition, mutation of residue 746 to Ala or Asn
resulted in significant increase in substrate transport, also
suggesting a role for this residue in translocation. H626
also appears to be involved since mutation to its equiva-
lent residue in F TraI does reduce translocation efficiency,
albeit to a lesser extent than the residues mentioned
previously. Finally, mutation R717 to Asn or 757 to Thr has
no effect. Thus, these results clearly define a surface on
TSA that is responsible for substrate recognition and
transport (shown in the oval in Fig. 3B). Since direct
binding between TraI and TraD has never been observed
(indicating either that the interaction is dominated by a
rapid koff or that a third partner might be involved either by
providing additional binding energy or by inducing confor-
mational changes in one of the binding partners resulting
in additional surfaces being involved in binding), we could
not confirm whether any of these mutations either reduces
or enhances interactions between the two proteins.
It was previously observed that infection of cells harbour-
ing the R1 plasmid by the R17 phage can be achieved in
the presence of a minimal fragment TraI1–992 comprising the
relaxase catalytic activity, the relaxase-associated ssDNA
binding site and TSA. Indeed, this protein fragment
together with the DNA is sufficient to activate the T4SS
channel for phage entry (Lang et al., 2011). This raises the
question as to whether the proposed recognition interface
on TSA is necessary for R17 phage infection and in turn for
the activation of the T4SS channel. In order to test this
hypothesis all the mutants that have been shown to par-
ticipate in substrate recognition have been tested in a
phage assay. Interestingly, all of them were able to support
phage infection at the same level as the wild-type protein
(Fig. S3). This indicates that although mutation of these
residues in the TraI1–992 impair efficient translocation of the
protein fragment, they were not sufficient to impair the
function of the TraI activation domain in nucleoprotein
import. This finding will need to be further investigated but
indicates that a wider range of protein–protein and/or
Fig. 4. Translocation assay of TSA variants. Relative translocation
frequencies (recombinants per donor cell) of the indicated variants
(left) were compared with wild-type Cre-TraI1–992 from plasmid R1
(grey bars). Values (expressed as percentage of wild type)
represent the mean of at least three independent experiments.
Standard deviations are shown (*P < 0.05; **P < 0.01;
***P < 0.001).
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protein–DNA interactions are involved in the activation
process.
Discussion
Relaxases are important proteins involved in DNA trans-
port by T4SS. These proteins form covalent nucleo-protein
complexes called relaxosomes which serve as substrate
for T4SS-mediated transport. Previous studies have
shown that two regions of the TraI relaxase encoded by the
R1 plasmid act as recognition signals, termed TSA and
TSB. This is unusual: typically, transport signal sequences
are short (5–25 residues) sequences located at either
the N- or C-terminal end of translocated substrates. For
example, translocation signals for the A. tumefaciens T4S
system or for the Dot/Icm T4S system from Legionella
pneumophila are small clusters of positively charged or
hydrophobic residues located at the C-terminus of the
translocated substrates (Nagai et al., 2005; Vergunst
et al., 2005). Translocation signals can however be more
complex: for example, the Bartonella effector proteins
have bipartite translocation signals where a charged
C-terminal residues region is combined with one or more
copies of a second motif located within the so-called ‘Bep
intracellular delivery (BID) domain’ inside the protein
sequence (Schulein et al., 2005). In TraI, TSA and TSB are
much longer sequences and they are located within the
protein sequence, not at the ends. Both function indepen-
dently from each other.
Because signal sequences are usually short, of unusual
amino acid composition, and generally located at either
the N- or C-terminal ends of translocated substrates, they
are believed to be unstructured. Moreover, attempts at
structurally characterizing internal translocation signal
regions of secreted effectors have been inconclusive. For
example, Voulhoux et al. (2000) identified a domain within
exotoxin A, a type II secretion system effector, which
appears to act as a translocation signal; however, the
functional characterization of this domain was based on
removing entire secondary structures (the domain con-
tains six helices) and the only helix (αF) deletion that
resulted in significantly reduced translocation is a crucial
structural secondary structure, the removal of which was
bound to drastically perturb the entire structure. A second
example is HasA, a type I secretion system effector (Masi
and Wandersman, 2010), where residues within the HasA
sequence were shown to affect translocation of the sub-
strate but did not cluster within any particular region of the
structure, indicating that the effects on translocation were
likely conformational, rather than impairing the targeting
of HasA to the secretion system.
Thus, with the work presented here, we demonstrate for
the first time that translocation signal sequences can (i)
fold into defined, well-characterized structures, and (ii) be
integrated structurally within the more extended scaffold
of proteins of well-known functions.
With its two terminal ends located near one another
and interacting in a two-stranded beta-sheet, TSA indeed
forms an independent folding unit, i.e. a self-contained
structural domain. Its three subdomains, 2A, 2B and
2B-like, are formed by sequence inserted within one
another, 2B within 2A and 2B-like within 2B. There is no
precedent for such an observation. Yet, folded TSs might
be more widespread that originally believed: for example,
the BID region of Bep proteins might also form folded
domains, although it cannot be excluded that the actual
sequences responsible for translocation by BID regions
might be located in disordered parts.
Remarkably, we show here that TSA is part of a more
extensive helicase structure. Indeed, the closest homo-
logue to TSA is domain 2 of canonical helicases. TSA is
known to reside in a larger ssDNA-binding domain, the
boundaries of which have recently been defined, extend-
ing from residues 381 and 858 (Cheng et al., 2011). The
structure of the N-terminal part of this domain from
residue 381 to 569 has been solved and shown to be
similar to subdomain 1A of SF1B helicases (Wright et al.,
2012). Thus, the ssDNA-binding region of TraI contains
three of the four canonical SF1B family subdomains, 1A,
2A and 2B. The parts of this domain, which have now
been structurally characterized, constitute 70% of the
entire sequence of the domain. Thus, it can be safely
concluded that the ssDNA-binding domain is a vestigial
helicase structure, which has lost its helicase activity but
retained its ssDNA-binding capability.
Finally, the TSA structure demonstrates that transloca-
tion signals can be part of defined, well-characterized and
larger structures supporting completely different function.
This is also an unprecedented observation. Translocation
signals are usually self-contained functional entity with no
associated function other than mediating specific sub-
strate recruitment to cognate transporters. Here we dem-
onstrate that TSA is part of a vestigial helicase structure.
Interestingly, TSB is also part of a helicase domain, but
this time, the domain has retained helicase activity. These
structural and functional features are clearly conserved
among relaxases. Whether they will turn out to be found in
other proteins remains to be demonstrated; however, TSA
provides a template that might well prove of general use
by transporters and secretion systems for interactions
with their cognate substrates.
Experimental procedures
Strains, plasmids and primers
All E. coli strains used in this study are described in Table S2.
Plasmids and Primers are described in Tables S3 and S4
respectively.
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Antibiotics, enzymes and reagents
Antibiotics were added at the indicated concentrations:
ampicillin (100 μg ml−1), chloramphenicol (10 μg ml−1), kana-
mycin (40 μg ml−1), spectinomycin (75 μg ml−1), tetracycline
(8 μg ml−1).
DNA preparation and PCR amplification
Plasmid DNA was purified from E. coli cells with the QIAprep
Spin Miniprep Kit (Qiagen, Hilden, Germany). Restriction
endonucleases and Antarctic phosphatase were purchased
from New England Biolabs, Beverly, MA, USA). T4 DNA
ligase was purchased from Fermentas GmBH (St. Leon-Rot,
Germany). DNA fragments for cloning were amplified using
Phusion High-Fidelity DNA Polymerase (Finnzymes Oy,
Espoo, Finland). Enzymes were used according to manufac-
turers’ recommendations.
Construction of the TSA overexpression plasmid
Expression construct of TSA (pCDF_TSA) with an N-terminal
6xHis tag and enterokinase cleavage site was generated by
inserting the PCR-amplified DNA from R1-16 between the
HindIII–BamHI sites in the pCDF1b vector.
Construction of Cre-fusion plasmids
CreTraIN992 was constructed by ligating the SalI fragment
from CreTraI(309–992) with SalI restricted CreTraIΔC1227.
The insert for CreTraIN992 F was amplified with primers
TraI_SFW1 and TraI_SRev5 from pOX38, cut with KpnI and
ligated with CFB B. Two-step PCR was used to generate
CreTraIN992 derivatives named for the corresponding point-
mutations in TSA. In the first step primer sets 1 (TraISe-
qFW2 + Forward-Primer with the desired mutation) and 2
(TraI_SRev5 + Reverse-Primer with the desired mutation)
were used to amplify two fragments from R1-16. In the second
step these two fragments were annealed and amplified with
primer set 3 (TraISeqFW2 + TraI_SRev5). The fragments
were cut with SalI and religated with CreTraIΔC1227.
Construction of expression plasmids
pGZTraIN992 derivatives were constructed in two steps: a
1.5 kb EcoRI/SalI fragment encoding the first 507 amino
acids of TraI was isolated from pCG02 and ligated in
pGZ119EH (Lessl et al., 1992) to generate pGZpartTraI. In
step two the traI coding region for amino acids 507–992 was
reconstructed by ligating the SalI fragment of desired
CreTraIN992 mutants in pGZpartTraI linearized with SalI.
Protein purification
For overexpression of R1 TraI_530–816, a 1 l culture of E. coli
BL21(DE3) star carrying pCDF_TSA was grown at 37°C in LB
medium containing 75 μg ml−1 spectinomycin to an A600 of 0.6,
when IPTG was added to 1 mM final concentration. After an
additional overnight incubation at 16°C, the cells were har-
vested by centrifugation and the pellets frozen at −80°C. Cells
were thawed overnight at 4°C, resuspended in 15 ml of buffer
I (50 mM sodium phosphate, 250 mM sodium chloride, 10 mM
Imidazole, 0.02% sodium azide, pH = 7.5), and lysed by two
passages through Emulsiflex-05 (AVESTIN). The soluble frac-
tion was obtained by ultracentrifugation at 21000 g for 1h. The
supernatant was filtered through a 0.45 μm filter prior to
loading to a HisTrap column (GE Healthcare) equilibrated in
buffer I. After washing the column with buffer I and 10% of
buffer II (buffer I containing 500 mM Imidazole), the protein
was eluted by applying a 50 ml gradient to 60% buffer II.
Fractions containing protein were adjusted with 3 M ammo-
nium sulphate to 1 M final concentration, combined and
loaded onto a HiTrap Phenyl HP column equilibrated with
buffer III (50 mM sodium phosphate, 100 mM sodium chloride,
1 mM EDTA pH = 8.0, 1 M ammonium sulphate, pH = 7.5).
After washing the column with three column volumes of 50%
buffer IV (50 mM sodium phosphate, 100 mM sodium chlo-
ride, 1 mM EDTA pH = 8.0, pH = 7.5), TSAΔC and full-length
TSAwere eluted sequentially by applying a 50–100% buffer IV
gradient. Fractions containing protein were combined and
concentrated with Amicon filter devices (Milipore) and the
protein was injected to a 120 ml Sephacryl 200 HR column
(GE Healthcare), equilibrated with buffer V (10 mM Tris
pH = 7.5, 150 mM magnesium chloride). The protein eluted as
a single peak. Fractions containing protein were concentrated
to 15 mg ml−1 and either immediately used for crystallization or
adjusted with glycerol to 40% (v/v) and stored at −80°C. The
apparent molecular mass of the full-length protein of 33.7 kDa
was confirmed by denaturating polyacrylamide gel electropho-
resis and Coomassie blue staining. The N-terminal five resi-
dues (IISEPD) of the TSAΔcryst were assessed by Edman
degradation analysis (PNAC Facility, University of Cam-
bridge). SeMet-containing TSAΔcryst was produced as recom-
mended by Molecular Dimension, and was purified using a
similar protocol as for the wild-type protein.
TSAΔcryst crystallization
TSAΔcryst was crystallized using the hanging drop vapour dif-
fusion method (McCoy et al., 2007) using a solution of 0.1 M
HEPES 7.5, 0.2 M sodium sulphate, 25% PEG 3350 as res-
ervoir at a temperature of 16°C. Crystals appear after 3 days.
TSAΔcryst crystallized in space group P41212, with unit cell
dimensions of a = b = 109.17 Å, c = 56.80 Å, and diffracted to
a resolution of 1.85 Å.
Structure determination
The SeMet-containing protein crystals of TSAΔcryst was used
for phasing. The data sets of the SeMet-TSA and native-TSA
were collected at beamline ID14-2 at the European Synchro-
tron Radiation Facility (ESRF). A data set was collected at the
wavelength of 0.8726 Å, and processed using the XDS suite.
The unmerged HKL file was converted into an mtz file using
POINTLESS. REINDEX and SCALA (Winn et al., 2011) were
used for scaling and separating the anomalous pairs. The
unmerged intensities were then converted into merged ampli-
tudes using C-TRUNCATE (Winn et al., 2011). Heavy atoms
search and SAD phases calculations were carried out using
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PHASER (McCoy et al., 2007). Phases were further
improved by solvent flattening using DM (Winn et al., 2011).
The solvent flattened phases were used for model building
using BUCCANEER (Winn et al., 2011). Building of the initial
model was completed manually using COOT. Restrained
refinement and one round of TLS refinement was performed
using REFMAC (Winn et al., 2011). The model was manually
inspected and corrected in COOT using 2Fo-Fc maps
(Emsley and Cowtan, 2004). The final model was validated
using PROCHECK (Winn et al., 2011).
Western blot analysis
For each sample a total of 2 ml mid-log-phase cells was
pelleted and resuspended in 80 mM Tris-HCl (pH = 6.8), 6%
DTT, 6% SDS, 12% glycerol and 0.04% bromophenol blue.
Samples were heated to 96°C for 10 min and centrifuged
afterwards. The equivalent of 0.1 A600 units was loaded on a
12.5% SDS-PAGE and run for 90 min at 10 mA. Transfer was
done overnight at 4°C at 90 mA onto a milllipore immobilon-P
membrane. Membranes were dried for 2 h at RT and soaked
briefly in 100% methanol before blocking overnight at 4°C in
1× TBS (20 mM Tris-HCl pH = 7.5, 150 mM NaCl) with 3%
BSA (albumin V). After washing two times for 5 min with TBS,
primary anti-Cre rabbit polyclonal antibody (Novagen,
69050-3) was used in TBS with 3% BSA (1:10 000 dilution)
for 2 h at RT. After washing [2 × 10 min with TBS, 1 × 10 min
with TBS + 0.1% Tween20 (TBST)] membrane was incubated
for 1 h at RT with peroxidase-conjugated anti-rabbit IgG
(Sigma, A0545). After 4 × 10 min washing with TBST, detec-
tion was done with an ECL-Kit (GE Healthcare).
CRAfT (Cre recombinase assay for translocation)
The Cre fusion reporter assay was performed as described
previously (Lang et al., 2010). E. coli MS411 carrying the
plasmids of interest and recipient CSH26Cm::LTL were used.
Donors were selected on plates containing appropriate anti-
biotics (see Table S2). Transconjugants and recombinants
were identified by plating serial dilutions on plates containing
kanamycin (40 μg ml−1) and X-Gal (100 μg ml−1) or chloram-
phenicol (10 μg ml−1) respectively. Conjugation and protein
translocation frequencies are calculated as transconjugants
or recombinants per donor respectively.
Infection studies with the male-specific phage R17
Fresh phage lysate was prepared as described previously
(Lang et al., 2011). Liquid infection assays as described in
Lang et al. (2011) were modified for 24-well cell culture plates
(Greiner Bio-one). Briefly, 900 μl LB medium containing
2 mM CaCl2 and the appropriate antibiotics were inoculated
to A600 0.02 with the desired strain. R17 phage lysate (100 μl)
was added to give a multiplicity of infection of 10. Cultures
were grown at 37°C with shaking and cell lysis was deter-
mined by measuring the A600 from 0 to 240 min post infection
using a xMarkTM Microplate Spectrophotometer (Bio-Rad).
Acknowledgements
We gratefully acknowledge V.K. Hunsur Rajendra and S.
Raffl for their help in constructing the Cre-fusion plasmids.
Work in the author’s laboratories was supported by the Aus-
trian Science Fund (FWF), P-24016 and DK W-901 Molecular
Enzymology, and the European Fund for Regional Develop-
ment and the province of Styria (A3-11.B-38/2011-6) (to
E.L.Z.), and Wellcome Trust Grant 098302 to G.W. We also
thank Dr Karin Wallden for help in data collection at beamline
ID 14-2 at ESRF. The coordinates have been deposited to the
PDB (entry code 4L0J).
References
Alvarez-Martinez, C.E., and Christie, P.J. (2009) Biological
diversity of prokaryotic type IV secretion systems. Microbiol
Mol Biol Rev 73: 775–808.
Cabezón, E., Sastre, J.I., and de la Cruz, F. (1997) Genetic
evidence of a coupling role for the TraG protein family in
bacterial conjugation. Mol Gen Genet 254: 400–406.
Cascales, E., and Christie, P.J. (2004) Definition of a bacterial
type IV secretion pathway for a DNA substrate. Science
304: 1170–1173.
Cheng, Y., McNamara, D.E., Miley, M.J., Nash, R., and
Redinbo, M.R. (2011) Functional characterization of the
multidomain F plasmid TraI relaxase-helicase. J Biol Chem
286: 12670–12682.
de la Cruz, F., Frost, L.S., Meyer, R.J., and Zechner, E.L.
(2010) Conjugative DNA metabolism in Gram-negative
bacteria. FEMS Microbiol Rev 34: 18–40.
Csitkovits, V.C., and Zechner, E.L. (2003) Extent of single-
stranded DNA required for efficient TraI helicase activity in
vitro. J Biol Chem 278: 48696–48703.
Dostal, L., and Schildbach, J.F. (2010) Single-stranded DNA
binding by F TraI relaxase and helicase domains is coor-
dinately regulated. J Bacteriol 192: 3620–3628.
Dostal, L., Shao, S., and Schildbach, J.F. (2011) Tracking F
plasmid TraI relaxase processing reactions provides insight
into F plasmid transfer. Nucleic Acids Res 39: 2658–2670.
Emsley, P., and Cowtan, K. (2004) Coot: model-building tools
for molecular graphics. Acta Crystallogr D Biol Crystallogr
60: 2126–2132.
Everett, R., and Willetts, N. (1980) Characterisation of an in
vivo system for nicking at the origin of conjugal DNA trans-
fer of the sex factor F. J Mol Biol 136: 129–150.
Fronzes, R., Christie, P.J., and Waksman, G. (2009) The
structural biology of type IV secretion systems. Nat Rev
Microbiol 7: 703–714.
Haft, R.J., Palacios, G., Nguyen, T., Mally, M., Gachelet,
E.G., Zechner, E.L., and Traxler, B. (2006) General
mutagenesis of F plasmid TraI reveals its role in conjuga-
tive regulation. J Bacteriol 188: 6346–6353.
Hamilton, H.L., Dominguez, N.M., Schwartz, K.J., Hackett,
K.T., and Dillard, J. (2005) Neisseria gonorrhoeae secretes
chromosomal DNA via a novel type IV secretion system.
Mol Microbiol 55: 1704–1721.
Holm, L., and Rosenstrom, P. (2010) Dali server: conserva-
tion mapping in 3D. Nucleic Acids Res 38: W545–W549.
Korolev, S., Hsieh, J., Gauss, G.H., Lohman, T.M., and
Waksman, G. (1997) Major domain swiveling revealed by
the crystal structures of complexes of E. coli Rep helicase
bound to single-stranded DNA and ADP. Cell 90: 635–647.
Kupelwieser, G., Schwab, M., Högenauer, G., Koraimann,
G., and Zechner, E.L. (1998) Transfer protein TraM stimu-
Structure of the TraI translocation signal domain 9
© 2013 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd., Molecular Microbiology
lates TraI-catalyzed cleavage of the transfer origin of
plasmid R1 in vivo. J Mol Biol 275: 81–94.
Lang, S., Gruber, K., Mihajlovic, S., Arnold, R., Gruber, C.J.,
Steinlechner, S., et al. (2010) Molecular recognition deter-
minants for type IV secretion of diverse families of conju-
gative relaxases. Mol Microbiol 78: 1539–1555.
Lang, S., Kirchberger, P.C., Gruber, C.J., Redzej, A., Raffl,
S., Zellnig, G., et al. (2011) An activation domain of plasmid
R1 TraI protein delineates stages of gene transfer initiation.
Mol Microbiol 82: 1071–1085.
Lessl, M., Balzer, D., Lurz, R., Waters, V.L., Guiney, D.G.,
and Lanka, E. (1992) Dissection of IncP conjugative
plasmid transfer: definition of the transfer region Tra2 by
mobilization of the Tra1 region in trans. J Bacteriol 174:
2493–2500.
Lu, J., Wong, J.J., Edwards, R.A., Manchak, J., Frost, L.S.,
and Glover, J.N. (2008) Structural basis of specific TraD–
TraM recognition during F plasmid-mediated bacterial con-
jugation. Mol Microbiol 70: 89–99.
McCoy, A.J., Grosse-Kunstleve, R.W., Adams, P.D., Winn,
M.D., Storoni, L.C., and Read, R.J. (2007) Phaser crystal-
lographic software. J Appl Crystallogr 40: 658–674.
Masi, M., and Wandersman, C. (2010) Multiple signals direct
the assembly and function of a type 1 secretion system. J
Bacteriol 192: 3861–3869.
Mihajlovic, S., Lang, S., Sut, M.V., Strohmaier, H., Gruber,
C.J., Koraimann, G., et al. (2009) Plasmid R1 conjugative
DNA processing is regulated at the coupling protein inter-
face. J Bacteriol 191: 6877–6887.
Nagai, H., Cambronne, E.D., Kagan, J.C., Amor, J.C., Kahn,
R.A., and Roy, C.R. (2005) A C-terminal translocation
signal required for Dot/Icm-dependent delivery of the
Legionella RalF protein to host cells. Proc Natl Acad Sci
USA 102: 826–831.
Nelson, W.C., Howard, M.T., Sherman, J.A., and Matson,
S.W. (1995) The traY gene product and integration host
factor stimulate Escherichia coli DNA helicase I-catalyzed
nicking at the F plasmid oriT. J Biol Chem 270: 28374–
28380.
Parker, C., and Meyer, R.J. (2007) The R1162 relaxase/
primase contains two, type IV transport signals that require
the small plasmid protein MobB. Mol Microbiol 66: 252–
261.
Ragonese, H., Haisch, D., Villareal, E., Choi, J.H., and
Matson, S.W. (2007) The F plasmid-encoded TraM protein
stimulates relaxosome-mediated cleavage at oriT through
an interaction with TraI. Mol Microbiol 63: 1173–1184.
Reygers, U., Wessel, R., Muller, H., and Hoffmann-Berling,
H. (1991) Endonuclease activity of Escherichia coli DNA
helicase I directed against the transfer origin of the F factor.
EMBO J 10: 2689–2694.
Rice, L.M., Earnest, T.N., and Brunger, A.T. (2000) Single-
wavelength anomalous diffraction phasing revisited. Acta
Crystallogr D Biol Crystallogr 56: 1413–1420.
Schröder, G., and Lanka, E. (2003) TraG-like proteins of type
IV secretion systems: functional dissection of the multiple
activities of TraG (RP4) and TrwB (R388). J Bacteriol 185:
4371–4381.
Schröder, G., Krause, S., Zechner, E.L., Traxler, B., Yeo,
H.J., Lurz, R., et al. (2002) TraG-like proteins of DNA trans-
fer systems and of the Helicobacter pylori type IV secretion
system: inner membrane gate for exported substrates? J
Bacteriol 184: 2767–2779.
Schulein, R., Guye, P., Rhomberg, T.A., Schmid, M.C.,
Schröder, G., Vergunst, A.C., et al. (2005) A bipartite signal
mediates the transfer of type IV secretion substrates of
Bartonella henselae into human cells. Proc Natl Acad Sci
USA 102: 856–861.
Subramanya, H.S., Bird, L.E., Brannigan, J.A., and Wigley,
D.B. (1996) Crystal structure of a DExx box DNA helicase.
Nature 384: 379–383.
Sut, M.V., Mihajlovic, S., Lang, S., Gruber, C.J., and Zechner,
E.L. (2009) Protein and DNA effectors control the TraI
conjugative helicase of plasmid R1. J Bacteriol 191: 6888–
6899.
Szpirer, C.Y., Faelen, M., and Couturier, M. (2000) Interaction
between the RP4 coupling protein TraG and the pBHR1
mobilization protein Mob. Mol Microbiol 37: 1283–1292.
Terradot, L., and Waksman, G. (2011) Architecture of the
Helicobacter pylori Cag-type IV secretion system. FEBS J
278: 1213–1222.
Vergunst, A.C., van Lier, M.C., den Dulk-Ras, A., Stuve, T.A.,
Ouwehand, A., and Hooykaas, P.J. (2005) Positive charge
is an important feature of the C-terminal transport signal of
the VirB/D4-translocated proteins of Agrobacterium. Proc
Natl Acad Sci USA 102: 832–837.
Voulhoux, R., Taupiac, M., Czjzek, M., Beaumelle, B., and
Filloux, A. (2000) Influence of deletions within domain II of
exotoxin A on its extracellular secretion from Pseudomonas
aeruginosa. J Bacteriol 182: 4051–4058.
Wallden, K., Rivera-Calzada, A., and Waksman, G. (2010)
Type IV secretion systems: versatility and diversity in func-
tion. Cell Microbiol 12: 1203–1212.
Winn, M.D., Ballard, C.C., Cowtan, K.D., Dodson, E.J.,
Emsley, P., Evans, P.R., et al. (2011) Overview of the
CCP4 suite and current developments. Acta Crystallogr D
Biol Crystallogr 67: 235–242.
Wong, J.J., Lu, J., Edwards, R.A., Frost, L.S., and Glover,
J.N. (2011) Structural basis of cooperative DNA recognition
by the plasmid conjugation factor, TraM. Nucleic Acids Res
39: 6775–6788.
Wong, J.J., Lu, J., and Glover, J.N. (2012) Relaxosome func-
tion and conjugation regulation in F-like plasmids – a struc-
tural biology perspective. Mol Microbiol 85: 602–617.
Wright, N.T., Raththagala, M., Hemmis, C.W., Edwards, S.,
Curtis, J.E., Krueger, S., and Schildbach, J.F. (2012) Solu-
tion structure and small angle scattering analysis of TraI
(381–569). Proteins 80: 2250–2261.
Zechner, E.L., Lang, S., and Schildbach, J.F. (2012) Assem-
bly and mechanisms of bacterial type IV secretion
machines. Philos Trans R Soc Lond B Biol Sci 367: 1073–
1087.
Supporting information
Additional supporting information may be found in the online
version of this article at the publisher’s web-site.
10 A. Redzej et al. ■
© 2013 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd., Molecular Microbiology
